Franklin FTSE South Korea ETF vs Revolution Medicines Inc. Common Stock — how do they compare? Franklin FTSE South Korea ETF trades at $58.41 (market cap $1.83B), while Revolution Medicines Inc. Common Stock trades at $191.11 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 22× Franklin FTSE South Korea ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Franklin FTSE South Korea ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Franklin FTSE South Korea ETF for 16 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| FLKR | RVMD | |
|---|---|---|
Market Cap | $1.83B | $40.32B |
Volume | 679,902 | 4,855,734 |
Sector | Broad Market / Factor | Health |
52-Week High | $72.25 | $221.15 |
52-Week Low | $27.09 | $47.50 |
Typical Hold Time | 16 Days | 0 Days |
Enterprise Value | — | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →